{"id":"https://openalex.org/W2521472373","doi":"https://doi.org/10.1002/cncr.30336","title":"Enzalutamide in castration\u2010resistant prostate cancer patients with visceral disease in the liver and/or lung: Outcomes from the randomized controlled phase 3 AFFIRM trial","display_name":"Enzalutamide in castration\u2010resistant prostate cancer patients with visceral disease in the liver and/or lung: Outcomes from the randomized controlled phase 3 AFFIRM trial","publication_year":2016,"publication_date":"2016-09-20","ids":{"openalex":"https://openalex.org/W2521472373","doi":"https://doi.org/10.1002/cncr.30336","mag":"2521472373","pmid":"https://pubmed.ncbi.nlm.nih.gov/27648814","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5632943"},"language":"en","primary_location":{"id":"doi:10.1002/cncr.30336","doi":"https://doi.org/10.1002/cncr.30336","is_oa":false,"landing_page_url":"https://doi.org/10.1002/cncr.30336","pdf_url":null,"source":{"id":"https://openalex.org/S126033908","display_name":"Cancer","issn_l":"0008-543X","issn":["0008-543X","1045-7410","1097-0142"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5632943","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5027991868","display_name":"Yohann Loriot","orcid":"https://orcid.org/0000-0002-8338-1739","observed_orcids":["https://orcid.org/0000-0002-8338-1739"]},"institutions":[{"id":"https://openalex.org/I277688954","display_name":"Universit\u00e9 Paris-Saclay","ror":"https://ror.org/03xjwb503","country_code":"FR","type":"education","lineage":["https://openalex.org/I277688954"]},{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Yohann Loriot","raw_affiliation_strings":["Department of Cancer Medicine, Gustave Roussy D\u00e9partement de M\u00e9decine Oncologique, Universit\u00e9 Paris\u2010Saclay, Villejuif  France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cancer Medicine, Gustave Roussy D\u00e9partement de M\u00e9decine Oncologique, Universit\u00e9 Paris\u2010Saclay, Villejuif  France","institution_ids":["https://openalex.org/I277688954","https://openalex.org/I2801843802"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007779528","display_name":"Karim S. Fizazi","orcid":"https://orcid.org/0000-0002-6068-9474","observed_orcids":["https://orcid.org/0000-0002-6068-9474"]},"institutions":[{"id":"https://openalex.org/I277688954","display_name":"Universit\u00e9 Paris-Saclay","ror":"https://ror.org/03xjwb503","country_code":"FR","type":"education","lineage":["https://openalex.org/I277688954"]},{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Karim Fizazi","raw_affiliation_strings":["Department of Cancer Medicine, Gustave Roussy D\u00e9partement de M\u00e9decine Oncologique, Universit\u00e9 Paris\u2010Saclay, Villejuif  France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cancer Medicine, Gustave Roussy D\u00e9partement de M\u00e9decine Oncologique, Universit\u00e9 Paris\u2010Saclay, Villejuif  France","institution_ids":["https://openalex.org/I277688954","https://openalex.org/I2801843802"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072378199","display_name":"Johann Sebastian De Bono","orcid":"https://orcid.org/0000-0002-2034-595X","observed_orcids":["https://orcid.org/0000-0002-2034-595X"]},"institutions":[{"id":"https://openalex.org/I125671874","display_name":"National Health Service","ror":"https://ror.org/02wnqcb97","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I125671874","https://openalex.org/I1311074006"]},{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Johann S. de Bono","raw_affiliation_strings":["The Royal Marsden National Health Service Foundation Trust and The Institute of Cancer Research, Sutton, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Royal Marsden National Health Service Foundation Trust and The Institute of Cancer Research, Sutton, United Kingdom","institution_ids":["https://openalex.org/I125671874","https://openalex.org/I142947616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016173669","display_name":"David Forer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405267655","display_name":"Medivation, Inc. (United States)","ror":"https://ror.org/03rkn0606","country_code":"US","type":"company","lineage":["https://openalex.org/I4405267655"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Forer","raw_affiliation_strings":["Medivation, Inc, San Francisco, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medivation, Inc, San Francisco, California","institution_ids":["https://openalex.org/I4405267655"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078059658","display_name":"Mohammad Hirmand","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405267655","display_name":"Medivation, Inc. (United States)","ror":"https://ror.org/03rkn0606","country_code":"US","type":"company","lineage":["https://openalex.org/I4405267655"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mohammad Hirmand","raw_affiliation_strings":["Medivation, Inc, San Francisco, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medivation, Inc, San Francisco, California","institution_ids":["https://openalex.org/I4405267655"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5072850546","display_name":"Howard I. Scher","orcid":"https://orcid.org/0000-0002-6791-9324","observed_orcids":["https://orcid.org/0000-0002-6791-9324"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Howard I. Scher","raw_affiliation_strings":["Memorial Sloan-Kettering Cancer Center, New York, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan-Kettering Cancer Center, New York, New York","institution_ids":["https://openalex.org/I1334819555"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5027991868"],"corresponding_institution_ids":["https://openalex.org/I277688954","https://openalex.org/I2801843802"],"apc_list":{"value":4790,"currency":"USD","value_usd":4790},"apc_paid":null,"fwci":3.8757,"has_fulltext":false,"cited_by_count":52,"citation_normalized_percentile":{"value":0.93707822,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":"123","issue":"2","first_page":"253","last_page":"262"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11221","display_name":"Bone health and treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10124","display_name":"Prostate Cancer Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/enzalutamide","display_name":"enzalutamide","score":0.9980000257492065},{"id":"https://openalex.org/keywords/castration-resistant-prostate-cancer","display_name":"castration-resistant prostate cancer","score":0.9559999704360962},{"id":"https://openalex.org/keywords/metastatic-prostate-cancer","display_name":"metastatic prostate cancer","score":0.781000018119812},{"id":"https://openalex.org/keywords/visceral-metastasis","display_name":"visceral metastases","score":0.968999981880188},{"id":"https://openalex.org/keywords/liver-metastases","display_name":"liver metastasis","score":0.9909999966621399},{"id":"https://openalex.org/keywords/lung-metastasis","display_name":"lung metastasis","score":1.0},{"id":"https://openalex.org/keywords/androgen-receptor-antagonists","display_name":"androgen receptor antagonists","score":0.9010000228881836},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.800000011920929},{"id":"https://openalex.org/keywords/radiographic-progression-free-survival","display_name":"radiographic progression-free survival","score":0.8659999966621399},{"id":"https://openalex.org/keywords/psa-response","display_name":"PSA response","score":0.9100000262260437},{"id":"https://openalex.org/keywords/radiographic-progression","display_name":"radiographic progression","score":0.7919999957084656},{"id":"https://openalex.org/keywords/affirm-trial","display_name":"AFFIRM trial","score":0.8820000290870667},{"id":"https://openalex.org/keywords/treatment-related-adverse-events","display_name":"treatment-related adverse events","score":0.6809999942779541},{"id":"https://openalex.org/keywords/safety-and-tolerability","display_name":"safety and tolerability","score":0.4620000123977661},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.5699999928474426}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9480646848678589},{"id":"https://openalex.org/C2776551883","wikidata":"https://www.wikidata.org/wiki/Q1996756","display_name":"Enzalutamide","level":5,"score":0.9308708310127258},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.7075562477111816},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.6892635226249695},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.5957553386688232},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5946717262268066},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.5080652236938477},{"id":"https://openalex.org/C67761136","wikidata":"https://www.wikidata.org/wiki/Q2105849","display_name":"Post-hoc analysis","level":2,"score":0.47301438450813293},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.4722192585468292},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4540574848651886},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.41051602363586426},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3661779761314392},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.35939162969589233},{"id":"https://openalex.org/C61367390","wikidata":"https://www.wikidata.org/wiki/Q416601","display_name":"Androgen receptor","level":4,"score":0.1347978413105011},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.13116738200187683},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001549","descriptor_name":"Benzamides","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008107","descriptor_name":"Liver Diseases","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D008171","descriptor_name":"Lung Diseases","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009570","descriptor_name":"Nitriles","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010669","descriptor_name":"Phenylthiohydantoin","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D010669","descriptor_name":"Phenylthiohydantoin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D016016","descriptor_name":"Proportional Hazards Models","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017430","descriptor_name":"Prostate-Specific Antigen","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018572","descriptor_name":"Disease-Free Survival","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D064129","descriptor_name":"Prostatic Neoplasms, Castration-Resistant","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D064129","descriptor_name":"Prostatic Neoplasms, Castration-Resistant","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1002/cncr.30336","doi":"https://doi.org/10.1002/cncr.30336","is_oa":false,"landing_page_url":"https://doi.org/10.1002/cncr.30336","pdf_url":null,"source":{"id":"https://openalex.org/S126033908","display_name":"Cancer","issn_l":"0008-543X","issn":["0008-543X","1045-7410","1097-0142"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"journal-article"},{"id":"pmid:27648814","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/27648814","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"Clinical Trial, Phase III"},{"id":"pmh:oai:europepmc.org:4661609","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5632943","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:5632943","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5632943","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Cancer","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:europepmc.org:4661609","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5632943","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8399999737739563}],"study_designs":[],"awards":[{"id":"https://openalex.org/G9000856728","display_name":"Cancer Center Support Grant","funder_award_id":"P30CA008748","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":28,"referenced_works":["https://openalex.org/W1491373660","https://openalex.org/W1904433804","https://openalex.org/W1963765725","https://openalex.org/W1979811833","https://openalex.org/W1999742227","https://openalex.org/W2003021334","https://openalex.org/W2004361934","https://openalex.org/W2019607817","https://openalex.org/W2055346449","https://openalex.org/W2065142831","https://openalex.org/W2103959341","https://openalex.org/W2108679313","https://openalex.org/W2117460748","https://openalex.org/W2119504728","https://openalex.org/W2120292596","https://openalex.org/W2123526148","https://openalex.org/W2137909325","https://openalex.org/W2139995572","https://openalex.org/W2141454098","https://openalex.org/W2147589066","https://openalex.org/W2148643283","https://openalex.org/W2159771669","https://openalex.org/W2165782799","https://openalex.org/W2166918329","https://openalex.org/W2167331614","https://openalex.org/W2170552969","https://openalex.org/W2311347322","https://openalex.org/W2325328650"],"related_works":["https://openalex.org/W2946666074","https://openalex.org/W2592991635","https://openalex.org/W2605272107","https://openalex.org/W2188431798","https://openalex.org/W3166124683","https://openalex.org/W4391112399","https://openalex.org/W2298315650","https://openalex.org/W2411189774","https://openalex.org/W2896515000","https://openalex.org/W4200390731"],"abstract_inverted_index":{"BACKGROUND:":[0],"Patients":[1,65],"with":[2,17,21,41,112,152,216,235,252,255],"metastatic":[3],"castration-resistant":[4],"prostate":[5],"cancer":[6],"(mCRPC)":[7],"and":[8,81,91,96,134,143,190,206],"visceral":[9,62,231,247],"metastases":[10,71,105,159,232,238,248],"have":[11,246,249],"a":[12,113,172,207],"worse":[13],"prognosis":[14],"than":[15,254],"those":[16,217],"nonvisceral":[18,237],"metastases.":[19],"Treatment":[20],"the":[22,28,44,47,50,57,92,230,236],"androgen":[23],"receptor":[24],"inhibitor":[25],"enzalutamide":[26,53,109,253],"in":[27,37,223],"phase":[29],"3":[30],"AFFIRM":[31,58],"trial":[32,59],"led":[33],"to":[34,94,198],"significant":[35],"improvements":[36],"outcomes":[38,251],"for":[39,76,229],"patients":[40,55,101,155,244],"mCRPC.":[42],"For":[43],"current":[45],"report,":[46],"authors":[48],"analyzed":[49],"efficacy":[51],"of":[52,116,176],"among":[54],"from":[56],"who":[60,66,102,156,218,245],"had":[61,67,103,157,163],"disease.":[63],"METHODS:":[64],"liver":[68,104],"and/or":[69],"lung":[70,158],"at":[72],"baseline":[73],"were":[74],"selected":[75],"prespecified":[77],"overall":[78],"survival":[79,137],"(OS)":[80],"exploratory":[82],"post":[83],"hoc":[84],"analyses,":[85],"including":[86],"prostate-specific":[87],"antigen":[88],"(PSA)":[89],"response":[90,146,210],"time":[93,197],"PSA":[95,145,199,209],"radiographic":[97,117,135,177],"progression.":[98],"RESULTS:":[99],"In":[100],"(n":[106,160],"=":[107,161],"92),":[108],"was":[110,227],"associated":[111],"lower":[114],"risk":[115,175],"progression":[118,178,200],"(hazard":[119],"ratio":[120],"[HR],":[121],"0.645;":[122],"95%":[123,169,181,203],"confidence":[124],"interval":[125],"[CI],":[126],"0.413-1.008),":[127],"improved":[128,164,184],"12-month":[129,185],"OS":[130,166,186],"(37.7%":[131],"vs":[132,140,149,188,193,213],"20.6%)":[133],"progression-free":[136],"(rPFS)":[138],"(11.6%":[139],"3.0%)":[141],"rates,":[142,195],"higher":[144],"rates":[147],"(35.1%":[148],"4.8%)":[150],"compared":[151,215,234],"placebo.":[153,220,256],"Enzalutamide-treated":[154],"104)":[162],"median":[165],"(HR,":[167,179,201],"0.848;":[168],"CI,":[170,182,204],"0.510-1.410),":[171],"substantially":[173],"reduced":[174],"0.386;":[180],"0.259-0.577),":[183],"(65.1%":[187],"55.3%)":[189],"rPFS":[191],"(30.9%":[192],"8.2%)":[194],"increased":[196],"0.358;":[202],"0.204-0.627),":[205],"better":[208,250],"rate":[211],"(52.1%":[212],"4.9%)":[214],"received":[219],"No":[221],"increase":[222],"treatment-related":[224],"adverse":[225],"events":[226],"observed":[228],"cohort":[233],"cohort.":[239],"CONCLUSIONS:":[240],"Across":[241],"multiple":[242],"endpoints,":[243],"Cancer":[257,262],"2017;123:253-262.":[258],"\u00a9":[259],"2016":[260],"American":[261],"Society.":[263]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":11},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-09-30T00:00:00"}